Breast Cancer and PET-CT Scan: Uses, Benefits, Procedure & Test Details

One of the most prevalent cancers in women is breast cancer. Treatment is targeted to each patient's specific case, so a proper diagnosis and evaluation are crucial to developing that plan. Breast cancer diagnosis and the evaluation of breast abnormalities often involve a mammography scan and sometimes ultrasound, breast MRI, and biopsy of the breast. A PET-CT scan is also recommended for selected patients to better understand the extent of the disease and to determine if cancer has spread to other areas of the body.

PET-CT is an examination which considers two imaging techniques: positron emission tomography (PET) and computed tomography (CT). PET gives information about metabolic activity within the tissues, and CT gives detailed information about the location and structure of abnormalities. When clinically suitable, these images are used in conjunction to more fully analyze breast cancer.

What Is a PET-CT Scan?

PET-CT is an examination that combines techniques of computed tomography (CT) and positron emission tomography (PET). A nuclear medicine technique that combines PET and CT imaging procedures into a single exam. A small amount of radioactive tracer is typically injected into a vein during a PET scan. FDG is a radioactive version of glucose that is used in many cases as a tracer. Extra sites of high activity are seen on the PET image because some cancer cells consume glucose more rapidly than many types of normal cells. Then, the CT offers information on the anatomy of the area, so that a doctor can pinpoint the exact location of increased activity.

Why Is PET-CT Used in Breast Cancer?

Not all women who have breast cancer need a PET scan and CT scan. The need for the scan depends on factors like symptoms of cancer, results of previous tests, and whether they have an increased risk that their cancer has spread or come back. PET-CT is useful in special cases to find out if breast cancer has spread to any other lymph nodes or parts of the body. It is also used to diagnose possible metastasis, to check the success of some treatments, and to rule out the presence of metastasis after treatment. For instance, PET-CT scans are ordered for some advanced breast cancer patients, or when there is a clinical suspicion of cancer spread to other parts of the body. The recommended imaging depends on cancer stage and the patient's particular circumstances.

PET-CT for Cancer: What Can It Show?

One of the important uses of a PET-CT scan for cancer is evaluating disease activity throughout the body. In breast cancer, it may help doctors:

• Look for areas of cancer that may have spread to other parts of the body.
• Evaluate suspicious lymph nodes or other abnormalities.
• Assess whether cancer is responding to treatment.
• Look for signs that cancer may have returned after treatment.
• Provide information that can help with treatment planning.

The use of PET-CT yields both functional and anatomic information in the same scan. This makes it easier for medical professionals to comprehend the location and relevance of abnormal findings.

What Are the Benefits of PET-CT in Breast Cancer?

1. Helps Evaluate Cancer Spread

One of the advantages of having a PET-CT is that it looks at parts of the body other than the breast and identifies any unusual internal activity in other areas of the body. Also helpful when doctors have to consider the potential for metastatic breast cancer.

2. Combines Functional and Anatomical Information

PET demonstrates increased metabolic activity, and CT demonstrates detailed anatomy. It is helpful for physicians to use both types of information to help find and interpret abnormal findings.

3. Can Help Assess Treatment Response

Selected PET-CT scans are used to assess whether the cancer is responding to the treatment. A change in metabolic activity sometimes is helpful to understand treatment response.

4. May Help Detect Recurrence

PET-CT is used as a test to identify the presence of any new breast cancer, depending on the symptoms and clinical situation.

5. Provides Whole-Body Information

If a whole-body PET-CT is performed, multiple areas are studied at one time. This is useful if you worry that the cancer has spread from where it first appeared.

PET-CT Scan Accuracy: How Reliable Is It?

When patients are thinking about PET scans, they often look for “PET CT scan accuracy”. Nevertheless, with breast cancer, there is no one-size-fits-all accuracy percentage. The value of PET-CT has several factors, such as the type and stage of breast cancer, the type of tracer used, size and position of the suspected abnormality, blood glucose level, and indication for the scan.

The results of a PET-CT also must be evaluated in the context of the symptoms, medical history, physical examination and other imaging or laboratory test results. Although it is true that increased uptake indicates an area of cancer, some non-cancerous conditions such as inflammation exhibit increased activity too. Likewise, smaller or less metabolically active lesions are not always evident. Thus, PET-CT is not meant to be a single test used to independently confirm each cancer diagnosis, and should be used appropriately to serve an important role in treatment planning and diagnosis.

What Are the Test Details of a PET-CT Scan?

Before the scan, patients usually receive specific preparation instructions. For many FDG PET-CT examinations, patients are asked not to eat for several hours before the scan and to drink water instead. People with diabetes may receive special instructions because blood sugar and insulin levels can affect the distribution of the tracer. A small amount of radioactive tracer is injected into a vein. The patient then rests quietly while the tracer travels through the body and is taken up by tissues. This waiting period is commonly around 30 to 60 minutes.

After this, the patient lies on the scanning table. The CT portion is performed first, followed by the PET images. The scanning itself usually takes around 30 minutes, although the total time at the centre can be longer because of preparation and tracer uptake.

Is PET-CT Safe?

PET-CT uses a small amount of radioactive material for imaging. The tracer loses radioactivity over time and is also eliminated from the body, mainly through urine. Patients are generally advised to drink plenty of water after the examination unless their doctor has advised otherwise. Because PET-CT involves radiation, it should be performed when the expected medical benefit justifies the exposure. Patients should tell their doctor if they are pregnant or may be pregnant. Women who are breastfeeding should also discuss this with their doctor or nuclear medicine team before the examination.

What Happens After a PET-CT Scan?

After the scan, a specialist in nuclear medicine or radiology reviews the images and prepares a report for the referring doctor. The report may describe areas of increased or decreased tracer uptake and other findings seen on the CT images. An abnormal PET-CT finding does not always mean cancer. Depending on the finding, the doctor may recommend another imaging test, follow-up imaging, laboratory testing, or a biopsy. Comparing the PET-CT with previous scans can also be important when evaluating changes over time.

When Should a Doctor Recommend PET-CT?

The decision to perform PET-CT should be based on the individual patient's medical situation. It may be considered when there is a concern about advanced disease, spread to other parts of the body, treatment response, or recurrence. For early-stage breast cancer, other breast imaging tests such as mammography, ultrasound and MRI may be more appropriate for evaluating the breast itself. PET-CT is therefore not a replacement for routine breast imaging or biopsy when those tests are indicated.

PET-CT at Molecular Diagnostics and Therapy

At Molecular Diagnostics and Therapy, advanced PET-CT imaging is available to support the evaluation of cancer and other medical conditions. PET-CT combines metabolic information with detailed anatomical imaging, helping specialists assess findings when the examination is clinically appropriate. The choice of PET-CT, tracer, and imaging protocol depends on the patient's condition and the purpose of the examination. Patients should follow the preparation instructions provided by their healthcare team and discuss their medical history, medications, diabetes status, allergies, and any possibility of pregnancy before the scan.

Conclusion

For some breast cancer patients, PET-CT is a key factor in their treatment. It is used to check for spread of the cancer, determine how the treatment is working, and detect a recurrence of the cancer. PET-CT also helps give information that might be helpful in a breast cancer investigation, if used in conjunction with anatomical information.

PET-CT, however, does not need to be performed on all women with breast cancer and should not be used as a screening breast cancer test. This varies according to the type, stage and symptoms of the cancer and previous test results. A specialist is able to decide if PET-CT is suitable and the significance of the results in relation to other tests.